ID   T47D/A1-2
AC   CVCL_0I95
SY   T47D(A1-2); T47D A1-2; A1-2
DR   cancercelllines; CVCL_0I95
DR   GEO; GSE141834
DR   Wikidata; Q54971573
RX   PubMed=2550815;
RX   PubMed=32170217;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Transfected with: RGD; 2741; Nr3c1.
CC   Omics: scRNAseq analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 13
//
RX   PubMed=2550815; DOI=10.1210/mend-3-8-1270;
RA   Nordeen S.K., Kuhnel B., Lawler-Heavner J., Barber D.A., Edwards D.P.;
RT   "A quantitative comparison of dual control of a hormone response
RT   element by progestins and glucocorticoids in the same cell line.";
RL   Mol. Endocrinol. 3:1270-1278(1989).
//
RX   PubMed=32170217; DOI=10.1038/s42003-020-0837-0;
RA   Hoffman J.A., Papas B.N., Trotter K.W., Archer T.K.;
RT   "Single-cell RNA sequencing reveals a heterogeneous response to
RT   glucocorticoids in breast cancer cells.";
RL   Commun. Biol. 3:126.1-126.11(2020).
//